vimarsana.com
Home
Live Updates
Defence Therapeutics Inc.: Defence's Melanoma Targeted Vacci
Defence Therapeutics Inc.: Defence's Melanoma Targeted Vacci
Defence Therapeutics Inc.: Defence's Melanoma Targeted Vaccine A1-Reprogrammed MSC (ARM) Cell Potency Validated
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company
Related Keywords
Canada ,
United Kingdom ,
Vancouver ,
British Columbia ,
British ,
Canadian ,
Sebastien Plouffe ,
Defence Therapeutics Inc ,
British Columbia Newsfile Corp ,
Defence Therapeutics ,
Statement Regarding ,
Defence ,
Herapeutics ,
Melanoma ,
Argeted ,
Vaccine ,
Deprogrammed ,
Fell ,
Potency ,
Validated ,